Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maximum Tolerated Dose”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT03443622
What this trial is testing

Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors

Who this might be right for
Refractory Solid Tumor
SupremeCure Pharma Inc.
Early research (Phase 1)Ended earlyNCT04267939
What this trial is testing

ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

Who this might be right for
Advanced Solid Tumors (Excluding Prostate Cancer)Ovarian Cancer
Bayer 14
Early research (Phase 1)Ended earlyNCT01930292
What this trial is testing

Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies

Who this might be right for
Solid Tumors
Debiopharm International SA 31
Early research (Phase 1)UnknownNCT04262739
What this trial is testing

MTD, Safety and Efficacy of NYH817G and NYH100P in Monotherapy and Combination in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Haim Bio Co., Ltd. 42
Testing effectiveness (Phase 2)Ended earlyNCT02314052
What this trial is testing

Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 21
Testing effectiveness (Phase 2)Study completedNCT00404092
What this trial is testing

Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis

Who this might be right for
Invasive Aspergillosis
University of Cologne 46
Early research (Phase 1)Study completedNCT00955812
What this trial is testing

STAT3 Inhibitor for Solid Tumors

Who this might be right for
Advanced CancerSolid Tumor
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT02168101
What this trial is testing

Determining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 9
Early research (Phase 1)Looking for participantsNCT05872295
What this trial is testing

IKS014 in Advanced Solid Tumors That Express HER2

Who this might be right for
Breast CancerGastric CancerGastroesophageal-junction Cancer
Iksuda Therapeutics Ltd. 165
Early research (Phase 1)Study completedNCT04666649
What this trial is testing

Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
University of Maryland, Baltimore 27
Early research (Phase 1)UnknownNCT04360317
What this trial is testing

Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer

Who this might be right for
Solid Tumor
Kyunghee University Medical Center 9
Early research (Phase 1)Study completedNCT01938638
What this trial is testing

Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Bayer 80
Early research (Phase 1)Study completedNCT00594126
What this trial is testing

Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Geron Corporation 20
Early research (Phase 1)Looking for participantsNCT03900793
What this trial is testing

Losartan + Sunitinib in Treatment of Osteosarcoma

Who this might be right for
Osteosarcoma
University of Colorado, Denver 41
Early research (Phase 1)Looking for participantsNCT06487481
What this trial is testing

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma (ACC)Recurrent Adrenocortical Carcinoma (ACC)Recurrent Abdominal Adrenocortical Carcinoma (ACC)+2 more
National Cancer Institute (NCI) 32
Early research (Phase 1)Study completedNCT03117101
What this trial is testing

Study of the AL3810 in the Treatment of Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumors
Haihe Biopharma Co., Ltd. 17
Testing effectiveness (Phase 2)Study completedNCT01283945
What this trial is testing

Study of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Institut de Recherches Internationales Servier 134
Testing effectiveness (Phase 2)Ended earlyNCT00537511
What this trial is testing

A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide

Who this might be right for
Carcinoma, Small Cell
Celgene 22
Early research (Phase 1)Active Not RecruitingNCT05241392
What this trial is testing

Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Beijing Tiantan Hospital 30
Early research (Phase 1)Looking for participantsNCT07104799
What this trial is testing

Momelotinib During and After HCT in Myelofibrosis

Who this might be right for
MyelofibrosisHematopoietic Cell Transplantation (HCT)
Massachusetts General Hospital 28
Next Page